Literature DB >> 16883289

Susceptibility of Aedes aegypti and Aedes albopictus to temephos in four study sites in Kuala Lumpur City Center and Selangor State, Malaysia.

C D Chen1, W A Nazni, H L Lee, M Sofian-Azirun.   

Abstract

Larvae obtained from Taman Samudera (Gombak, Selangor), Kampung Banjar (Gombak, Selangor), Taman Lembah Maju (Cheras, Kuala Lumpur) and Kampung Baru (City centre, Kuala Lumpur) were bioassayed with diagnostic dosage (0.012 mg/L) and operational dosage (1 mg/L) of temephos. All strains of Aedes aegypti and Aedes albopictus showed percentage mortality in the range of 16.00 to 59.05 and 6.4 to 59.50 respectively, after 24 hours. LT50 values for the 6 strains of Ae. aegypti and Ae. albopictus were between 41.25 to 54.42 minutes and 52.67 to 141.76 minutes respectively, and the resistance ratio for both Aedes species were in the range of 0.68 to 1.82 when tested with operational dosage, 1 mg/L temephos. These results indicate that Aedes mosquitoes have developed some degree of resistance. However, complete mortality for all strains were achieved after 24 hours when tested against 1 mg/L temephos.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16883289

Source DB:  PubMed          Journal:  Trop Biomed        ISSN: 0127-5720            Impact factor:   0.623


  13 in total

1.  Temephos-induced resistance in Aedes aegypti and its cross-resistance studies to certain insecticides from India.

Authors:  S N Tikar; Arkaja Kumar; G B K S Prasad; Shri Prakash
Journal:  Parasitol Res       Date:  2009-02-20       Impact factor: 2.289

2.  Residual effects of TMOF-Bti formulations against 1(st) instar Aedes aegypti Linnaeus larvae outside laboratory.

Authors:  A N Saiful; M S Lau; S Sulaiman; O Hidayatulfathi
Journal:  Asian Pac J Trop Biomed       Date:  2012-04

3.  Studies on insecticide susceptibility of Aedes aegypti (Linn) and Aedes albopictus (Skuse) vectors of dengue and chikungunya in Andaman and Nicobar Islands, India.

Authors:  Arun Sivan; A N Shriram; I P Sunish; P T Vidhya
Journal:  Parasitol Res       Date:  2015-09-07       Impact factor: 2.289

4.  Insecticide susceptibility of Aedes aegypti and Aedes albopictus in Central Africa.

Authors:  Basile Kamgang; Sébastien Marcombe; Fabrice Chandre; Elysée Nchoutpouen; Philippe Nwane; Josiane Etang; Vincent Corbel; Christophe Paupy
Journal:  Parasit Vectors       Date:  2011-05-15       Impact factor: 3.876

5.  Multi-insecticide susceptibility evaluation of dengue vectors Stegomyia albopicta and St. aegypti in Assam, India.

Authors:  Kavita Yadav; Bipul Rabha; Sunil Dhiman; Vijay Veer
Journal:  Parasit Vectors       Date:  2015-03-03       Impact factor: 3.876

6.  Insecticide susceptibility and dengue vector status of wild Stegomyia albopicta in a strategically important area of Assam, India.

Authors:  Sunil Dhiman; Bipul Rabha; Kavita Yadav; Indra Baruah; Vijay Veer
Journal:  Parasit Vectors       Date:  2014-07-01       Impact factor: 3.876

7.  Inheritance Pattern of Temephos Resistance, an Organophosphate Insecticide, in Aedes aegypti (L.).

Authors:  Vinaya Shetty; Deepak Sanil; N J Shetty
Journal:  Genet Res Int       Date:  2015-03-16

8.  Contrasting patterns of insecticide resistance and knockdown resistance (kdr) in the dengue vectors Aedes aegypti and Aedes albopictus from Malaysia.

Authors:  Intan H Ishak; Zairi Jaal; Hilary Ranson; Charles S Wondji
Journal:  Parasit Vectors       Date:  2015-03-25       Impact factor: 3.876

9.  Camino Verde (The Green Way): evidence-based community mobilisation for dengue control in Nicaragua and Mexico: feasibility study and study protocol for a randomised controlled trial.

Authors:  Neil Andersson; Jorge Arostegui; Elizabeth Nava-Aguilera; Eva Harris; Robert J Ledogar
Journal:  BMC Public Health       Date:  2017-05-30       Impact factor: 3.295

10.  Community cost-benefit discussions that launched the Camino Verde intervention in Nicaragua.

Authors:  Carlos Hernandez-Alvarez; Jorge Arosteguí; Harold Suazo-Laguna; Rosa Maria Reyes; Josefina Coloma; Eva Harris; Neil Andersson; Robert J Ledogar
Journal:  BMC Public Health       Date:  2017-05-30       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.